PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17365587-7	2007	In single-pollutant models, the strongest associations were observed at lag 3 for a 10-microg/m3 increase of TSP (2.7% increase in ER, 95% CI 0.7-4.6) and PM10 (3.0% increase, 95% CI 0.4-5.7), and at lag 4 for a 10-microg/m3 increase of NO2 (11.0% increase in ER, 95% CI 3.6-18.8).	Nitrogen Dioxide	237-240	lymphocyte activating 3	Homo sapiens	72-77	
34411816-7	2021	The positive association only appeared for NO2: positive associations between SAB and NO2 were observed in both single-day models (lag 0, lag 1, lag 3, and lag 4) and cumulative exposure models (lag 01, lag 03, and lag 05) and the most significant effects were observed at lag 05 (3.289%; 95% CI: 1.568%, 5.011%).	Nitrogen Dioxide	43-46	lymphocyte activating 3	Homo sapiens	145-150	
34411816-7	2021	The positive association only appeared for NO2: positive associations between SAB and NO2 were observed in both single-day models (lag 0, lag 1, lag 3, and lag 4) and cumulative exposure models (lag 01, lag 03, and lag 05) and the most significant effects were observed at lag 05 (3.289%; 95% CI: 1.568%, 5.011%).	Nitrogen Dioxide	86-89	lymphocyte activating 3	Homo sapiens	145-150	
34203021-7	2021	NO2 had statistically significant effects at lag2, lag3, and lag4.	Nitrogen Dioxide	0-3	lymphocyte activating 3	Homo sapiens	51-55	
21432566-9	2010	A 10 mug/m(3) increase in suspended particulate matter (SPM) and nitrogen dioxide (NO(2)) at lag2-lag3 were significantly associated with an increase in asthma hospitalization with ORs of 1.041 (95% CI 1.013-1.070) and 1.112 (95% CI 1.022-1.209), respectively.	Nitrogen Dioxide	65-81	lymphocyte activating 3	Homo sapiens	98-102	
32746628-4	2022	An increase in NO2 level by 10 mug/m3 was related to an increase in the daily number of outpatients by 5.43% (95% confidence interval [CI]: 2.25%, 8.70%) at lag0, by 4.35% (95% CI: 1.15%, 7.66%) at lag1, and by 3.21% (95% CI: 0.05%, 6.47%) at lag3.	Nitrogen Dioxide	15-18	lymphocyte activating 3	Homo sapiens	243-247